- Report
- May 2024
- 191 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- November 2023
- 100 Pages
Global
From €5653EUR$5,950USD£4,863GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- May 2024
- 353 Pages
Global
From €5320EUR$5,600USD£4,577GBP
- Report
- November 2023
- 145 Pages
Global
From €2374EUR$2,499USD£2,042GBP
- Report
- November 2023
- 150 Pages
Global
From €4228EUR$4,450USD£3,637GBP
- Report
- February 2024
- 227 Pages
Global
€4745EUR$4,995USD£4,082GBP
- Report
- December 2023
- 150 Pages
Middle East, Africa
From €2361EUR$2,485USD£2,031GBP
€3373EUR$3,550USD£2,901GBP
- Report
- March 2024
- 193 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- October 2023
- 110 Pages
Global
From €5653EUR$5,950USD£4,863GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- May 2024
- 193 Pages
Global
From €4703EUR$4,950USD£4,045GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- July 2023
- 128 Pages
Global
From €7125EUR$7,500USD£6,129GBP
- Drug Pipelines
- April 2024
- 450 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Clinical Trials
- April 2024
- 106 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1425EUR$1,500USD£1,226GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1425EUR$1,500USD£1,226GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1425EUR$1,500USD£1,226GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1425EUR$1,500USD£1,226GBP
The Botulinum Toxin market is a subset of the biotechnology industry that focuses on the production and sale of botulinum toxin, a neurotoxin produced by the bacterium Clostridium botulinum. Botulinum toxin is used in a variety of medical and cosmetic applications, including the treatment of muscle spasms, wrinkles, and excessive sweating. It is also used to treat a variety of neurological disorders, such as dystonia and blepharospasm.
The Botulinum Toxin market is highly competitive, with a number of companies offering products for both medical and cosmetic applications. Companies in the market include Allergan, Ipsen, Merz, Revance Therapeutics, and Galderma. These companies are engaged in research and development, manufacturing, and marketing of botulinum toxin products. Additionally, there are a number of smaller companies that specialize in the production of botulinum toxin for specific applications. Show Less Read more